Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques.
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
ISSN: 1525-0024
Titre abrégé: Mol Ther
Pays: United States
ID NLM: 100890581
Informations de publication
Date de publication:
10 May 2024
10 May 2024
Historique:
received:
24
01
2024
revised:
21
04
2024
accepted:
09
05
2024
medline:
12
5
2024
pubmed:
12
5
2024
entrez:
12
5
2024
Statut:
aheadofprint
Résumé
HTLV-1 infection occurs by cell-to-cell transmission and can induce fatal adult T-cell leukemia (ATL). Vaccine development is critical for the control of HTLV-1 transmission. However, determining whether vaccine-induced anti-Env antibodies can prevent cell-to-cell HTLV-1 transmission is challenging. Here, we examined the protective efficacy of a vaccine inducing anti-Env antibodies against HTLV-1 challenge in cynomolgus macaques. Eight of ten vaccinated macaques produced anti-HTLV-1 neutralizing antibodies (NAbs) and were protected from an intravenous challenge with 10
Identifiants
pubmed: 38734900
pii: S1525-0016(24)00323-X
doi: 10.1016/j.ymthe.2024.05.020
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.